SSY Group Limited — Board/Management Information 2012

Apr 5, 2012

Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement, make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this announcement.

==> picture [283 x 113] intentionally omitted <==

(Incorporated in the Cayman Islands with limited liability)

(Stock Code: 2005)

RESIGNATION OF EXECUTIVE DIRECTOR

The board of directors (the “ Board ”) of Lijun International Pharmaceutical (Holding) Co., Ltd. (the “ Company ”) announces that Ms. Zhang Guifu (“ Ms. Zhang ”) has resigned as an executive director of the Company with effect from 5 April 2012 in order to devote more time to her other business commitments.

Ms. Zhang has confirmed that there is no disagreement between her and the Board or the Company and there are no matters relating to her resignation that need to be brought to the attention of the shareholders of the Company or The Stock Exchange of Hong Kong Limited.

The Board would like to take this opportunity to express its appreciation to Ms. Zhang for her valuable contribution to the Company during her tenure of office as an executive director of the Company.

By order of the Board Chow Hing Yeung Company Secretary

Hong Kong, 5 April 2012

As at the date of this announcement, the Board comprises Mr. Wu Qin, Mr. Qu Jiguang, Mr. Xie Yunfeng, Mr. Huang Chao, Mr. Wang Xianjun, Mr. Duan Wei, Mr. Bao Leyuan and Ms. Gao Shuping as executive Directors, and Mr. Wang Yibing, Mr. Leung Chong Shun and Mr. Chow Kwok Wai as independent non-executive Directors.

1